Menu
← Oncology Approval Tracker
FDA DECISION ·
Lupron Depot
leuprolide acetate · AbbVie
Open LinkedIn brief ↓1 min read · estimated
APPROVED USE
What FDA approved
Treatment of advanced prostate cancer. FDA removed the palliative qualifier from the previously labeled advanced-prostate-cancer indication.
LAMPGEN ANALYSIS
Why it matters
The revised indication changes the purpose wording for the existing advanced disease population.
What research teams should watch
Use the current label wording in protocols and keep the specific depot strength and interval explicit.
PRIMARY RECORDS